Influencing Factors for the Acceptability of Accessing HIV Pre-exposure Prophylaxis via Community Pharmacies in Wales

被引:0
|
作者
Gillespie, David [1 ]
Williams, Adam D. N. [1 ]
Ma, Richard [2 ]
Couzens, Zoe [3 ]
Hood, Kerenza [1 ]
Hughes, Dyfrig A. [4 ]
Mantzourani, Efi [5 ]
Cochrane, Eleanor [6 ]
Wood, Fiona [7 ,8 ]
机构
[1] Cardiff Univ, Coll Biomed & Life Sci, Ctr Trials Res, Sch Med, Cardiff, Wales
[2] Univ Bristol, Ctr Acad Primary Care, Bristol Med Sch, Bristol, England
[3] Publ Hlth Wales NHS Trust, Cardiff, Wales
[4] Bangor Univ, Ctr Hlth Econ & Med Evaluat, Bangor, Wales
[5] Cardiff Univ, Coll Biomed & Life Sci, Sch Pharm, Cardiff, Wales
[6] Hlth Educ & Improvement Wales, Cardiff, Wales
[7] Cardiff Univ, Coll Biomed & Life Sci, Sch Med, Div Populat Med, Cardiff, Wales
[8] Cardiff Univ, Coll Biomed & Life Sci, PRIME Ctr Wales, Sch Med, Cardiff, Wales
关键词
community pharmacy; healthcare access; HIV; pre-exposure prophylaxis; primary care; qualitative research;
D O I
10.1111/hex.70247
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Introduction: HIV prevention methods, such as pre-exposure prophylaxis (PrEP), have been a significant contributing factor to a global decline in HIV transmission. PrEP has been available through the NHS in Wales since 2017. However, access is exclusively via sexual health clinics, and those accessing PrEP do not reflect those being diagnosed with HIV. Widening access beyond sexual health clinics may be one approach to encourage more equitable uptake, and there is growing interest in offering PrEP services in community pharmacies. We, therefore, aimed to explore the acceptability of PrEP services being delivered through community pharmacies among prospective service users. Methods: We conducted a qualitative interview study of people living in Wales who either (i) currently access, (ii) previously accessed or are (iii) considering accessing PrEP via a sexual health clinic. Participants were recruited via community networks, and interviews were conducted virtually. Our topic guide was informed by Levesque's conceptual framework of access to healthcare, and we used reflexive thematic analysis. Results: We interviewed 24 participants and included data from 20 in the analysis. Four themes were generated: experiences of accessing PrEP via sexual health clinics, the prospect of PrEP access via community pharmacies, other community settings in which PrEP may be accessed and concerns around integrated healthcare and healthcare data. Conclusion: PrEP access via community pharmacy is likely to be an acceptable option for people. There are uncertainties surrounding what a PrEP service would look like in a community pharmacy setting, and this would need clarifying to prospective users to increase the salience of access. Patient and Public Contribution: A team-based approach was taken for developing the topic guide and agreeing on the codes for this study. This included people with lived experience of accessing PrEP in Wales.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Application of Bayesian networks to identify factors influencing acceptability of HIV pre-exposure prophylaxis in Guilin, China
    Lingmi Zhou
    Wuxiang Shi
    Sawitri Assanangkornchai
    Panupong Vichitkunakorn
    Jie Tang
    Scientific Reports, 12
  • [2] Application of Bayesian networks to identify factors influencing acceptability of HIV pre-exposure prophylaxis in Guilin, China
    Zhou, Lingmi
    Shi, Wuxiang
    Assanangkornchai, Sawitri
    Vichitkunakorn, Panupong
    Tang, Jie
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [3] Transformation of Australian Community Pharmacies Into Good Clinical Practice Compliant Trial Pharmacies for HIV Pre-Exposure Prophylaxis
    Lal, Luxi
    Ryan, Kathleen
    Liu, Iris Yi
    Price, Brian
    Lockwood, Timmy
    Aguirre, Ivette
    Slobodian, Peter
    Lam, Ada
    Vassan, Manoj
    Lim, Kie
    Silverii, John
    Tesoriero, Joseph
    Phu, Johnny
    Lim, Wan
    Naidoo, Bharathy
    Russell, Nick
    Rundle, Matthew
    Sewell, Rowan
    Cooper, Craig
    Hardman, Alexander
    Quinn, Martin
    Mak, Anne
    Wright, Edwina J.
    Wright, Edwina
    Stoove, Mark
    Ruth, Simon
    Batrouney, Colin
    West, Michael
    Murphy, Dean
    de Wit, John
    Audsley, Jennifer
    Chang, Christina
    El-Hayek, Carol
    Duncan, Alison
    Sasadeusz, Joe
    Allan, Brent
    Whelan, Michael
    McPhail, Daniel
    Wilson, David
    Vujovic, Olga
    Holt, Martin
    Williams, Chris
    Wesselingh, Steve
    Ward, James
    Gallant, Danny
    Ward, Alison
    Asselin, Jason
    Spelman, Tim
    Lockwood, John Timothy
    Chong, Alistair
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [4] Acceptability of and willingness to use HIV pre-exposure prophylaxis in community Pharmacy users in Uganda
    Nakate, Vivian
    Bagaya, Irene
    Hamill, Matthew M.
    Kiragga, Agnes
    Kyambadde, Peter
    Manabe, Yukari C.
    Melendez, Johan H.
    Musaazi, Joseph
    Onzia, Annet A.
    Parkes-Ratanshi, Rosalind
    SEXUALLY TRANSMITTED DISEASES, 2024, 51 (01) : S304 - S305
  • [5] HIV pre-exposure prophylaxis
    Sharma, Malika
    Tan, Darrell H. S.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2014, 186 (15) : E588 - E588
  • [6] HIV Pre-Exposure Prophylaxis
    Liegeon, Geoffroy
    Delaugerre, Constance
    Molina, Jean-Michel
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2024, 38 (03) : 453 - 474
  • [7] HIV: Pre-exposure Prophylaxis
    Singh, Ajai Kumar
    Singh, Ashish
    Singh, Deepti
    Singh, Manish
    Singh, Pratibha
    Sharma, Abhishek
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2012, 3 (12) : 900 - 901
  • [8] HIV pre-exposure prophylaxis
    Fougere, Edouard
    ACTUALITES PHARMACEUTIQUES, 2024, 63 (638): : 14 - 16
  • [9] HIV pre-exposure prophylaxis
    Morin, Stephen F.
    Yamey, Gavin
    Rutherford, George W.
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
  • [10] Online Prescriptions to HIV Pre-Exposure Prophylaxis and Pre-Exposure Prophylaxis Uptake
    Wille, Lexie
    Parent, Mike C.
    AIDS PATIENT CARE AND STDS, 2020, 34 (12) : 499 - 501